A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 6, 2007, Pages 691-700

  Stelmach, Iwona ^a   Grzelewski, Tomasz ^a   Bobrowska Korzeniowska, Monika ^a   Stelmach, Piotr ^b   Kuna, Piotr ^b  

^a N Copernicus Hospital   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Asthma; Budesonide; Children; Formoterol; Montelukast; Pulmonary function

Indexed keywords

BUDESONIDE; FORMOTEROL; MONTELUKAST; PLACEBO; SALBUTAMOL;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; MEDICAL ASSESSMENT; MONOTHERAPY; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACETATES; ADOLESCENT; AIRWAY RESISTANCE; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MAXIMAL MIDEXPIRATORY FLOW RATE; PLETHYSMOGRAPHY, WHOLE BODY; QUINOLINES; RESPIRATORY FUNCTION TESTS;

EID: 34548838846     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.08.003     Document Type: Article

References (53)

1. NIH Publication. Global Strategy for Asthma Management and Prevention. No. 02-3659 issued January, 1995. Updated 2004 from the 2003 document.
2. Skoner D.P. Outcome measures in childhood asthma. Pediatrics 109 (2002) 393-398
3. Sharek P.J., Mayer M.L., Loewy L., Robinson T.N., Shames R.S., Umetsu D.T., et al. Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma. Pediatrics 110 (2002) 797-804
4. Black J., Baxter-Jones A.D., Gordon J., Findlay A.L., and Helms P.J. Assessment of airway function in young children with asthma: comparison of spirometry, interrupter technique, and tidal flow by inductance plethsmography. Pediatr Pulmonol 37 (2004) 548-553
5. Davis S.D. Neonatal and pediatric respiratory diagnostics. Respir Care 48 (2003) 367-385
6. Hellinckx J., De Boeck K., Bande-Knops J., van der Poel M., and Demedts M. Bronchodilator response in 3-6,5 yeras old healthy and stable asthmatic children. Eur Respir J 12 (1998) 438-443
7. Malmberg L.P., Pelkonen A., Poussa T., Pohianpalo A., Haahtela T., and Turpeinen M. Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging 22 (2002) 64-71
8. Sly P.D., and Lombardi E. Measurement of lung function in preschool children using the interrupter technique. Thorax 58 (2003) 742-744
9. Bisgaard H., and Klug B. Lung function measurement in awake young children. Eur Respir J 8 (1995) 2067-2075
10. Nakaie C.M., Rozov T., and Manissadjian A. A comparative study of clinical score and lung function tests in the classification of asthma by severity of disease. Rev Hosp Clin Fac Med Sao Paulo 53 (1998) 68-74
11. Studnicka M., Frischer T., and Neumann M. Determinants of reproducibility of lung function tests in children aged 7 to 10 years. Pediatr Pulmonol 25 (1998) 238-243
12. Bousquet J., Aubier M., Sastre J., Izquierdo J.L., Adler L.M., Hofbauer P., et al. Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. Allergy 61 (2006) 72-78
13. Bjermer L., Bisgaard H., Bousquet H.J., Fabbri L.M., Greening A.P., Haahtela T., et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomized, comparative trial. Br Med J 327 (2003) 891-896
14. Riccioni G., Della Veccia R., D'Orazio N., Sensi S., and Guagnano M.T. Comparison of montelukast and budesonide on bronchial reactivity in subjects with mild-moderate persistent asthma. Pulm Pharmacol Ther 16 (2003) 111-114
15. Christian Virchow J., Prasse A., Naya I., Summerton L., and Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med 162 (2000) 578-585
16. Price D.B., Hernandez D., Magyar P., Fiterman J., Beeh K.M., James I.G., et al. Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 58 (2003) 211-216
17. Vaquerizo M.J., Casan P., Castillo J., Perpina M., Sanchis J., Sobradillo V., et al. CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 58 (2003) 204-210
18. Bisgaard H. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 36 (2003) 391-398
19. 2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Cochrane Database Syst Rev 18 (2005) CD005307
20. Rabe K.F., Vermeire P.A., Soriano J.B., and Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 16 (2000) 802-807
21. van den Berg N.J., of ten Have W.H., Nagelkerke A.F., Bindels P.J., van der Palen J., and van Aalderen W.M. What general practitioners and paediatricians think about their patients' asthma. Patient Educ Couns 59 (2005) 182-185
22. Hanania N.A. Revisiting asthma control: How should it best be defined?. Pulm Pharmacol Ther (2006) in press
23. Eid N., Yandell B., Howell L., Eddy M., and Sheikh S. Can peak expiratory flow predict airflow obstruction in children with asthma?. Pediatrics 105 (2000) 354-358
24. Bjermer L. Past and future perspectives in the asthma treatment. Resp Med 95 (2001) 703-719
25. Ferguson A.C. Persisting airway obstruction in asymptomatic children with asthma with normal peak expiratory flow rates. J Alergy Clin Immunol 82 (1988) 19-22
26. Bye M.R., Kerstein D., and Barsh E. The importance of spirometry in the assessment of childhod asthma. Am J Dis Child 146 (1992) 977-978
27. Olaguibel J.M., Alvarez-Puebla M.J., Anda M., Gomez B., Garcia B.E., Tabar A.I., et al. Comparative analysis of the bronchodilator response measured by impulse oscillometry (IOS), spirometry and body plethysmography in asthmatic children. J Invest Allergol Clin Immunol 15 (2005) 102-106
28. Larsen G., June-Ku B.K., Guilbert T., and Morgan W. Assessing respiratory function in young children: developmental considerations. J Allergy Clin Immunol 115 (2005) 657-666
29. Quanjer Ph.H, editor. Standardisation of lung function tests. 1993 Update. Report Working Party for the European Community for Steel and Coal. Eur Respir J 1993; 6 (Suppl. 16).
30. Quanjer Ph.H., Helms P., Bjure J., and Gaultier C.I. Standardisation of lung function tests in pediatrics. Eur Respir J 2 Suppl. 4 (1989)
31. Crapo R.O., Hankinson J.L., and Irvin C. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152 (1995) 1107-1136
32. Klug B., and Bisgaard H. Measurement of the specific airway resistance by plethysmography in young children accompanied by an adult. Eur Respir J 10 (1996) 1599-1605
33. Merkus P.J., Mijnsbergen J.Y., Hop W.C., and de Jongste J.C. Interrupter resistance in preschool children: measurement characteristics and reference values. Am J Respir Crit Care Med 163 (2001) 1350-1355
34. Bisgaard H., and Nielsen K.G. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am J Respir Crit Care Med 162 (2000) 187-190
35. von Berg A., and Berdel D. Formoterol and salbutamol metered aerosols: comparison of a new and an established beta-2-agonist for their bronchodilating efficacy in the treatment of childhood bronchial asthma. Pediatr Pulmonol 7 (1989) 89-93
36. Kozlik-Feldmann R., von Berg A., Berdel D., and Reinhardt D. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma. Eur J Med Res 1 (1996) 465-470
37. Pao C.S., and McKenzie S.A. Randomized controlled trial of fluticasone in preschool children with intermittent wheeze. Am J Respir Crit Care Med 166 (2002) 945-949
38. Nielsen K.G., and Bisgaard H. Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer. Am J Respir Crit Care Med 164 (2001) 256-259
39. Szefler S.J., Phillips B.R., Martinez F.D., Chinchilli V.M., Lemanske R.F., Strunk R.C., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 115 (2005) 233-242
40. Stelmach I., Jerzynska J., and Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol 109 (2002) 257-263
41. O'Byrne P.M., Pedersen S., Busse W.W., Tan W.C., Chen Y.Z., Ohlsson S.V., et al. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 129 (2006) 1478-1485
42. Reiss T.F., Sorkness C.A., Stricker W., Botto A., Busse W.W., Kundu S., et al. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 52 (1997) 45-48
43. Tal A., Simon G., Vermeulen J.H., Petru V., Cobos N., Everard M.L., et al. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma. Pediatr Pulmonol 34 (2002) 342-350
44. Stelmach I., Majak P., Jerzynska J., and Kuna P. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma. Clin Exp Allergy 35 (2005) 213-220
45. Knorr B., Matz J., Bernstein J.A., Nguyen H., Seidenberg B.C., Reiss T.F., et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. J Am Med Assoc 279 (1998) 1181-1186
46. Tonelli M., Zignoni M., Bacci E., Dente F.L., Di Franco A., Giannini D., et al. Short-term effect of the addition of leukotriene receptor antagonists to the current therapy in severe asthmatics. Pulm Pharmacol Ther 16 (2003) 237-240
47. Nieto A., Pamies R., Oliver F., Medina A., Caballero L., and Mazon A. Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study). Respir Med 100 (2006) 1180-1185
48. Currie G.P., Lee D.K., Dempsey O.J., Fowler S.J., Cowan L.M., and Lipworth B.J. A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics. Br J Clin Pharmacol 55 (2003) 609-615
49. Cengizlier R., Demirpolat E., Tulek N., and Cakmak F. Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids. Ann Allergy Asthma Immunol 84 (2000) 539-541
50. Shapiro G.G., Mendelson L.M., and Pearlman D.S. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids. Ann Allergy Asthma Immunol 86 (2001) 633-640
51. Nielsen K.G., and Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. Am J Respir Crit Care Med 162 (2000) 1500-1506
52. Spahn J.D., Covar R.A., Jain N., Gleason M., Shimamoto R., Szefler S.J., et al. Effect of montelukast on peripheral airflow obstruction in children with asthma. Ann Allergy Asthma Immunol 96 (2006) 541-549
53. Tomac N., Tuncer A., Saraclar Y., and Adalioglu G. Efficacy of salmeterol in the treatment of childhood asthma. Acta Paediatr Jpn 38 (1996) 489-494